Athens Medical C.S.A., together with its subsidiaries, owns and operates hospital units in Greece and internationally.
Price History & Performance
|Historical stock prices|
|Current Share Price||€1.77|
|52 Week High||€1.07|
|52 Week Low||€1.96|
|1 Month Change||-2.75%|
|3 Month Change||7.93%|
|1 Year Change||45.08%|
|3 Year Change||70.19%|
|5 Year Change||164.18%|
|Change since IPO||1.69%|
Recent News & Updates
Athens Medical C.S.A (ATH:IATR) Seems To Use Debt Quite Sensibly
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
There's Been No Shortage Of Growth Recently For Athens Medical C.S.A's (ATH:IATR) Returns On Capital
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
There May Be Reason For Hope In Athens Medical C.S.A's (ATH:IATR) Disappointing Earnings
Soft earnings didn't appear to concern Athens Medical C.S.A.'s ( ATH:IATR ) shareholders over the last week. We did...
|IATR||GR Healthcare||GR Market|
Return vs Industry: IATR exceeded the Greek Healthcare industry which returned 6.9% over the past year.
Return vs Market: IATR exceeded the Greek Market which returned -9.8% over the past year.
Stable Share Price: IATR is not significantly more volatile than the rest of Greek stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: IATR's weekly volatility (5%) has been stable over the past year.
About the Company
Athens Medical C.S.A., together with its subsidiaries, owns and operates hospital units in Greece and internationally. The company offers diagnosis and treatment for breast, gastrointestinal, hematologic, liver and pancreatic, lungs, prostate, skin, bladder and kidney, and gynecological cancers; and robotic, and neurosurgeons and spine surgery services, as well as treatments for heart diseases. It also provides medical services for range of orthopedics, such as foot and ankle, hand and wrist, hip, knee, shoulder, and spine; sports injuries; and chronic diseases, including diabetes, endocrinology, heat failure, high blood pressure, pain management, respiratory system, stroke, and thyroid conditions.
Athens Medical C.S.A Fundamentals Summary
|IATR fundamental statistics|
Is IATR overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|IATR income statement (TTM)|
|Cost of Revenue||€167.20m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.14|
|Net Profit Margin||5.57%|
How did IATR perform over the long term?See historical performance and comparison
Is Athens Medical C.S.A undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: IATR (€1.77) is trading above our estimate of fair value (€0.74)
Significantly Below Fair Value: IATR is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: IATR is good value based on its PE Ratio (12.5x) compared to the European Healthcare industry average (23.2x).
PE vs Market: IATR is good value based on its PE Ratio (12.5x) compared to the Greek market (14.8x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate IATR's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: IATR is good value based on its PB Ratio (1.7x) compared to the XE Healthcare industry average (2.3x).
How is Athens Medical C.S.A forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Athens Medical C.S.A has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Athens Medical C.S.A performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: IATR has high quality earnings.
Growing Profit Margin: IATR became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: IATR has become profitable over the past 5 years, growing earnings by 25.9% per year.
Accelerating Growth: IATR has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: IATR has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (40.8%).
Return on Equity
High ROE: IATR's Return on Equity (13.6%) is considered low.
How is Athens Medical C.S.A's financial position?
Financial Position Analysis
Short Term Liabilities: IATR's short term assets (€170.0M) do not cover its short term liabilities (€238.7M).
Long Term Liabilities: IATR's short term assets (€170.0M) exceed its long term liabilities (€100.0M).
Debt to Equity History and Analysis
Debt Level: IATR's debt to equity ratio (153.6%) is considered high.
Reducing Debt: IATR's debt to equity ratio has reduced from 247.1% to 153.6% over the past 5 years.
Debt Coverage: IATR's debt is not well covered by operating cash flow (14.3%).
Interest Coverage: IATR's interest payments on its debt are well covered by EBIT (4.9x coverage).
What is Athens Medical C.S.A current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate IATR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate IATR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if IATR's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if IATR's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: IATR is not paying a notable dividend for the Greek market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of IATR's dividend in 3 years as they are not forecast to pay a notable one for the Greek market.
How experienced are the management team and are they aligned to shareholders interests?
Dr. Vassilis G. Apostolopoulos serves as Chief Executive Officer of Athens Medical Center SA. and served as its Vice President. Dr. Apostolopoulos serves as a Director of Athens Medical Center SA.He serve...
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Athens Medical C.S.A.'s employee growth, exchange listings and data sources
- Name: Athens Medical C.S.A.
- Ticker: IATR
- Exchange: ATSE
- Founded: 1984
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: €153.523m
- Shares outstanding: 86.74m
- Website: https://www.athexgroup.gr/company-profile/-/select-company/230
Number of Employees
- Athens Medical C.S.A.
- 5-7 Distomou Street
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/14 21:20|
|End of Day Share Price||2021/10/14 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.